David Buck
Stock Analyst at B. Riley Securities
(0.26)
# 4,393
Out of 5,127 analysts
12
Total ratings
25%
Success rate
-29.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Buck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MNOV MediciNova | Assumes: Buy | $22 | $1.42 | +1,449.30% | 2 | Mar 25, 2019 | |
| SUPN Supernus Pharmaceuticals | Maintains: Buy | $68 → $65 | $51.17 | +27.03% | 3 | Nov 12, 2018 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $219 → $190 | $160.25 | +18.56% | 4 | Nov 8, 2018 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $26 → $28 | $13.20 | +112.12% | 2 | Aug 22, 2018 | |
| ALKS Alkermes | Initiates: Buy | $60 | $29.60 | +102.70% | 1 | Jun 6, 2018 |
MediciNova
Mar 25, 2019
Assumes: Buy
Price Target: $22
Current: $1.42
Upside: +1,449.30%
Supernus Pharmaceuticals
Nov 12, 2018
Maintains: Buy
Price Target: $68 → $65
Current: $51.17
Upside: +27.03%
Jazz Pharmaceuticals
Nov 8, 2018
Maintains: Buy
Price Target: $219 → $190
Current: $160.25
Upside: +18.56%
Amneal Pharmaceuticals
Aug 22, 2018
Maintains: Buy
Price Target: $26 → $28
Current: $13.20
Upside: +112.12%
Alkermes
Jun 6, 2018
Initiates: Buy
Price Target: $60
Current: $29.60
Upside: +102.70%